Description
by Everest Pharmaceuticals is a generic version of Resmetirom, used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults with moderate to advanced liver fibrosis. Here’s an overview of its key features:
-
: Each tablet contains 80 mg of Resmetirom.
-
: Used for adults diagnosed with NASH accompanied by moderate to advanced liver fibrosis.
-
: Reduces hepatic fat accumulation, potentially halting disease progression by improving fibrosis and resolving NASH without worsening fibrosis.
-
: Taken orally once daily with or without food. The recommended dosage is 80 mg for patients weighing less than 100 kg1.
-
: Common side effects include diarrhea, nausea, vomiting, itching, and dizziness1.
-
: Everest Pharmaceuticals Ltd., Bangladesh.
-
: Available for supply worldwide, with specific packaging details not mentioned.
English
Arabic
Reviews
There are no reviews yet.